Credit Suisse Group Reiterates GBX 670 Price Target for Tate & Lyle (BD15)
A number of other brokerages also recently issued reports on BD15. Kepler Capital Markets set a GBX 690 ($9.67) price objective on Tate & Lyle and gave the stock a neutral rating in a research report on Friday, November 3rd. Jefferies Group set a GBX 750 ($10.52) price objective on Tate & Lyle and gave the stock a buy rating in a research report on Monday, October 23rd. Finally, Goldman Sachs Group set a GBX 695 ($9.74) price objective on Tate & Lyle and gave the stock a neutral rating in a research report on Wednesday. One analyst has rated the stock with a sell rating, six have given a hold rating and two have issued a buy rating to the company. The company has a consensus rating of Hold and an average price target of GBX 697.22 ($9.78).
Shares of Tate & Lyle (BD15) remained flat at $GBX 111.50 ($1.56) during trading hours on Thursday. The stock has a market cap of $2,800.00 and a P/E ratio of 210.38. Tate & Lyle has a 12-month low of GBX 102 ($1.43) and a 12-month high of GBX 116 ($1.63).
Tate & Lyle Company Profile
Tate & Lyle PLC is a provider of ingredients and solutions to the food, beverage and other industries. The Company’s segments include Speciality Food Ingredients and Bulk Ingredients. The Speciality Food Ingredients segment’s product categories include dairy, beverage, bakery and convenience. The Bulk Ingredients segment’s product lines include bulk sweeteners for food and beverage customers, and industrial starches for paper and construction industries.
Receive News & Ratings for Tate & Lyle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle and related companies with MarketBeat.com's FREE daily email newsletter.